Effects of Novel Estrogens on Glucose and Lipids in Postmenopausal Prediabetic Women Veterans

NCT05073237 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

FED

Sponsor class

Stopped withdrawn

Conditions

Menopause
Prediabetes
Obesity

Interventions

OTHER: Placebo
DRUG: conjugated estrogens/bazedoxifene (CE/BZA)

Sponsor

VA Office of Research and Development